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Abstract HIV disclosure can help people living with HIV
to access social support, enhance antiretroviral adherence,
facilitate engagement in care and reduce unprotected sex.
Given interpersonal risks associated with HIV disclosure,
however, anxiety about sharing one’s status is common. To
investigate anxiety about HIV disclosure in HIV-positive
populations, we conducted a systematic review of quali-
tative and quantitative studies, with 119 studies included.
The review demonstrated that perceived interpersonal risks
are associated with HIV disclosure and outlined evidence
of associations with anxiety, fear and worry. We present a
new cognitive model of HIV disclosure anxiety adapted
from clinical theories of health and social anxiety, con-
sistent with evidence from the review. The model attempts
to explain the development and maintenance of anxiety in
individuals whose functioning is most affected by concerns
about sharing their status. Implications for helping people
living with HIV struggling with significant levels of anxi-
ety about HIV disclosure are discussed.
Keywords HIV disclosure  Anxiety  Fear  Cognitive 
Model
Introduction
HIV disclosure (sharing one’s HIV positive status with
others) has a number of potentially positive consequences.
HIV partner disclosure can reduce levels of unprotected
sexual activity, partly through greater condom negotiation
and use [1–3], and facilitate partner HIV testing [1]. Sharing
one’s status to partners or others can improve engagement
in care [1, 4], and help in the initiation of and adherence to
antiretroviral treatment (ART) [5], through the availability
of disclosure-specific support or the reduced need to hide
medication from others [6]. There may also be psycholog-
ical benefits to status sharing. Well-being may be enhanced
(although evidence is equivocal [7]) through increased
social support [8], the development of more helpful cog-
nitive appraisal of HIV-related stressors and enhanced self-
esteem [9, 10]. HIV disclosure may reduce anxiety levels,
although again, evidence is equivocal [1, 7].
Given the potential individual and public health benefits
associated with HIV disclosure, the process of sharing
one’s status with others could be thought of as a helpful
health behaviour. HIV disclosure, however, exposes the
person living with HIV (PLHIV) to potential rejection and
discrimination. This is the case whether HIV disclosure is
direct (the PLHIV telling others about their status), indirect
(somebody else revealing the PLHIV’s status to others), or
guessed (others concluding that the PLHIV is HIV-posi-
tive) [11]. In addition, once one’s status is shared with a
particular individual, it cannot be unshared. Given the
interpersonal risks associated with HIV disclosure, anxiety
about sharing one’s status is likely to be the norm, gener-
ally serving to inhibit HIV disclosure. Concerns about
other people knowing one’s HIV status may be heightened
to the extent that very little or no HIV disclosure takes
place. This can contribute to feelings of social isolation
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[12]. There may be some situations, however, when anxiety
is influential in motivating disclosure rather than non-dis-
closure (e.g., when the PLHIV is concerned about others
finding out about one’s status from a third party).
Some models of health behaviour recognise the impor-
tance of anxiety. The Self-Regulatory Model of Illness
Behaviour [13] suggests that fear and anxiety (amongst
other emotional and cognitive factors) influences coping
with health threats. Fear is also included in the Protection
Motivation Theory [14] as a factor that influences beha-
vioural intentions and health behaviour.
To investigate the nature of anxiety about HIV disclo-
sure in HIV-positive populations, we conducted a system-
atic review. As rates of HIV disclosure (and potentially the
nature of HIV disclosure anxiety) differ according to
context (e.g., the characteristics of the person living with
HIV, the disclosure recipient, route of infection, whether
disclosure is direct, indirect or guessed, and the time since
diagnosis [11, 15, 16]), our review adopted an inclusive
approach to study eligibility.
Method
Study Eligibility Criteria
Studies were included in the review if they:
1. Were empirical, reporting primary data;
2. Included HIV-positive participants;
3. Reported or measured anxiety, worry or fear about
HIV disclosure or one’s HIV status being shared;
4. Referred to the PLHIV sharing their HIV status with
others, others sharing the PLHIV’s status with third
parties, or others guessing the PLHIV’s status;
5. Assessed the association between anxiety/worry/fear
about sharing one’s HIV status and any outcome, or
cited disclosure anxiety/worry/fear as a reason for non-
disclosure or any other outcome.
Sources of Information and Search Strategy
Studies published in peer-reviewed journals were retrieved
from the electronic databases Pubmed/Medline and Psy-
chINFO. There was no date restriction. The searches were
conducted using combinations of the following terms: ‘anxi-
ety’, ‘fear’, ‘worry’ and ‘HIV disclosure’ in either the title or
abstract. The searches were conducted on 2nd January 2015.
Data Collection and Abstraction
The first author carried out the initial searches. All dupli-
cations were removed. The first author screened the
remaining titles and abstracts for eligibility. A random
sample of 20 % of the articles at this stage was indepen-
dently rated by both the first author and a second reviewer
(an undergraduate psychology student). Inter-rater relia-
bility was calculated using Cohen’s Kappa. The value for
Cohen’s Kappa was 0.78, p\ 0.01, suggesting a good
level of inter-rater reliability. Articles considered relevant
were retrieved in full text. These articles were then asses-
sed for eligibility by both reviewers. Exclusions were
reported, with reasons given.
Data was extracted for the following study characteris-
tics (by the undergraduate psychology student, verified by
the first author): authors; date of publication; location;
design; methodology; nature of the sample including sex
and age; nature of disclosure recipient; and findings relat-
ing to HIV disclosure anxiety.
Results
After duplicates were removed, there were 426 articles.
159 articles were screened in as potentially eligible. 119 of
these articles were subsequently considered eligible for the
review. Most commonly articles were rejected as they did
not report on anxiety about HIV disclosure.
Figure 1 summarises the review process.
Study characteristics are summarised in Supplementary
Table 1.
Study Characteristics
Fifty-one of the studies took place in Africa, with a further
39 studies in North America. Fifteen studies took place in
Asia, with 8 in Europe, 4 in South America and 2 in
Australasia. There were three intervention studies [17–19].
The remainder of the studies were cross sectional.
The most commonly used method to capture data was
qualitative interviews (64 studies). Surveys were used in 43
studies, with focus groups in 18 studies. The other
approaches used were self-report questionnaires (8 studies)
and participant observations (3 studies). Fifteen of the
studies used more than one method.
Participants and Disclosure Recipients
Sample sizes ranged from four to 775 (median sample size
52, IQR 26–164). Most commonly (59 studies), partici-
pants did not belong to a specific subgroup of HIV-positive
individuals. Twenty-three studies were based on parent
samples. Other studies sampled ethnic minority groups
(eight studies), individuals taking ART (six studies), ado-
lescents (five studies), and MSM (three studies). The
remainder (15 studies) sampled from diverse populations
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(e.g., intervention participants, sex workers and prisoners).
Seventy-seven of the studies sampled both males and
females, 32 accessed female only samples, and ten studies
sampled males only. The disclosure recipient was not
specified in 77 of the studies. HIV disclosure to one’s
partner was the focus of 24 studies. Other studies focused
on disclosure to children (nine studies), family and friends
(five studies), work colleagues (three studies) and dentists
(one study).
Qualitative and Survey Findings
The most commonly reported reason for non-disclosure or
disclosure anxiety theme was the fear of discrimination or
stigmatising responses from others (58 studies). Anxiety
about rejection and abandonment (e.g., divorce from part-
ner) was also reported frequently (54 studies) with the
specific fear of partner violence cited in 18 studies. Anxiety
about secondary/indirect disclosure (disclosure recipients
sharing one’s status with others) was commonly reported
(17 studies), as was the concern about causing stress, worry
and burden to others if they were disclosed to (15 studies).
There were a range of other disclosure anxiety themes
reported, including the fear of being blamed, worries about
being isolated, anxiety about feeling guilty and ashamed,
and concerns about losing one’s job.
Anxiety about HIV disclosure was reported to be a
barrier to ART initiation or adherence in 14 studies, and to
engagement in care for oneself or one’s child in eight
studies. HIV disclosure anxiety was given as a reason for
being isolated or lacking social support in five studies and
was mentioned as a barrier to safer sex (e.g., condom use)
in three studies.
Quantitative Findings
A range of statistical associations with anxiety about HIV






























(n =12: no clear evidence 
of anxiety about disclosure 
(6); not HIV+ sample (3); 
no empiricial data (2); fear 
of secondary disclosure (1)




(n = 26: no clear evidence 
of anxiety about disclosure
(19); duplicates (3); not 
HIV+ sample (2); 
paediatric HIV disclosure 






Fig. 1 Study search process. From: Moher et al. [46]
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associations with psychological variables were assessed.
‘HIV disclosure concerns’ was related to higher levels of
general anxiety in two studies [20, 21]. One study found a
statistically significant relationship between ‘HIV disclo-
sure concerns’ and depression [21], but a different study
failed to find this association [20]. The latter study also
failed to find an association between ‘HIV disclosure
concerns’ and life satisfaction but did find an association
with reduced social support [20]. ‘HIV disclosure con-
cerns’ were associated with higher levels of HIV stigma in
two studies [21, 22], and were associated with negative
self-image, greater disengagement coping, less time since
diagnosis, less primary control engagement and lower self-
esteem in one study [21].
In relation to demographic and clinical variables, ‘HIV
disclosure concerns’ was greater in females compared to
males in one study [23], and in heterosexual compared with
homosexual/bisexual participants in three studies [23–25].
‘HIV disclosure concerns’ were greater in individuals
without an AIDS diagnosis in two studies [24, 25], and
greater in those with lower CD4 counts, no HIV-related
hospitalisations, no partner, and of younger age in one
study [25].
Discussion
The review suggests that anxiety about disclosing one’s
HIV status is highly prevalent across region and popula-
tion. Fears about rejection and discrimination from others
appear ubiquitous. More generally, anxiety seemed to
focus on the possibility of negative effects for the indi-
vidual living with HIV in the context of interpersonal
relationships. There were also, however, frequently repor-
ted concerns about the effect on others of sharing one’s
HIV status. There is some evidence from qualitative studies
included in the review that negative consequences of
anxiety about HIV disclosure, in terms of reduced ART
adherence, poor engagement in care, and isolation, may
occur. Importantly, participants themselves often cited
fears about HIV disclosure as a reason for such negative
outcomes. No quantitative studies examined these
relationships.
The review was limited by the fact that most of the
studies were qualitative in nature. In addition, the few
quantitative studies were cross sectional with only a limited
range of correlates examined. Hence, it was not possible to
quantify the extent to which HIV disclosure anxiety is
related to other psychological and behavioural factors or to
examine the causes and consequences of HIV disclosure
anxiety from the studies. Further, the majority of studies
did not specify to whom the person living with HIV was
disclosing. This is important as disclosure anxiety may
differ depending on the recipient.
Models of HIV Disclosure
There is a long tradition of developing models of HIV
disclosure separate from models of the disclosure of other
health conditions [26]. This may reflect specific issues
associated with HIV (e.g., HIV stigma) and the fact that
HIV disclosure may facilitate reductions in onward trans-
mission. Given the likely importance of anxiety about
disclosing one’s HIV status, it is surprising that explana-
tory models of HIV disclosure have rarely included anxiety
as a central construct. A recent systematic review of HIV
disclosure models [27] found that individual cognitive
determinants of HIV disclosure were commonly cited in
models (e.g., self-efficacy and perceived disclosure risks
and benefits), but affect, including anxiety, was not.
Indeed, neither the presence of anxiety nor how it is
develops and can be maintained has been included in HIV
disclosure theories. Not all disclosure decisions are likely
to be influenced by anxiety but our systematic review
suggestions that anxiety about HIV disclosure is common
and may have important consequences. We suggest that
high and persistent levels of anxiety about disclosure may
have an impact on an individual’s quality of life and
potentially their social and occupational functioning.
A new theoretical model of HIV disclosure anxiety
(rather than of disclosure behaviour) may help to direct
clinicians towards interventions that help to support people
with HIV with significant levels of anxiety and preoccu-
pation about sharing their status with others. This may be
particularly important where anxiety about HIV disclosure
is having a large impact on the individual’s psychological
and relational functioning and their engagement with care.
Aims of Our Model
We present a new model of HIV disclosure anxiety that
draws upon existing cognitive models of anxiety disorders
to explain how high levels of anxiety about sharing one’s
status with others develops and can be maintained. The
approach of drawing on theoretical models relating to
affect rather than of heath behaviour is novel in the HIV
context. For example, the Health Belief Model [28] was the
most commonly used model used in a recent review of
psychological correlates of HIV testing [29], and the
Information Motivation Behavioural Skills Model [30]
(based on the Theory of Planned Behaviour [31]) has
guided much recent research on antiretroviral adherence.
Such models primarily outline cognitive determinants of
behaviour. It may be, however, that affect is another
important determinant of many HIV-related behaviours.
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For example, consistent relationships between fear of HIV
and HIV testing on the one hand and HIV testing itself on
the other hand, have been reported [29]. It may also be that
affect (particularly anxious affect) plays a key role in
driving many HIV disclosure decisions. Of greater rele-
vance for our model, however, is the possibility that high
levels of anxiety about disclosure affects individuals’
quality of life and their social and occupational functioning
(through processes such as avoidance leading to social
isolation).
Existing cognitive models of anxiety disorders empha-
sise cognitive and behavioural factors that maintain anxiety
and minimise quality of life. Models of social anxiety [32]
are particularly relevant as HIV disclosure is a social
phenomenon. Models of health anxiety [33] are also rele-
vant given the nature of the condition and the context of
care and treatment. Such cognitive models attempt to
integrate cognitive, affective and behavioural factors and
have clear treatment implications. Existing cognitive
models of anxiety disorders cannot be applied in their
entirety, however. There are specific characteristics asso-
ciated with HIV that require an HIV-specific model,
including the extent of HIV stigma, and the infectious
nature of the condition. In addition, models of social anx-
iety [32] have self-focused attention at their core, whereas
our systematic review suggests that it is the fear of the
response of others which is central to HIV disclosure
anxiety. Models of health anxiety [33] also suggest that
self-directed interpretations (of symptoms) are key rather
than interpersonal factors.
Our model is designed to apply to individuals who have
high levels of anxiety about HIV disclosure (e.g. a per-
sistent fear of disclosure, with intense anxiety about one’s
status being known) that has a significant impact on their
functioning (e.g., significant interference with their normal
routine, occupational/academic functioning, or social
activities or relationships). This may be manifested in
individuals being preoccupied with thoughts about not
telling others that they are HIV-positive (direct disclosure),
or about avoiding people finding out that they are HIV
positive (indirect or guessed disclosure). The model is
intended to apply to situations where the PLHIV fears their
HIV-positive status will be shared (i.e., where they are
motivated to avoid disclosure) or to situations where they
want to or feel they have to disclose but are anxious about
doing so (i.e., where to some extent the PLHIV is moti-
vated to disclose). That is, anxiety is only likely to char-
acterise situations where there is a level of motivation to
either disclose or to avoid disclosure.
Our model attempts to explain why some individuals are
more affected by anxiety about sharing their status than
others and why some situations are more anxiety-provok-
ing than others, despite the ubiquitous nature of HIV
disclosure anxiety. We argue, however, that levels of HIV
disclosure anxiety are on a continuum both between people
and within people (depending on the disclosure recipient
and over time). At lower levels of anxiety about HIV dis-
closure, this may not interfere with decisions about sharing
one’s status and may have a minimal impact on quality of
life. The model aims to be consistent with existing evi-
dence about HIV disclosure anxiety and HIV disclosure
rates.
A Model of HIV Disclosure Anxiety
The model is outlined in Fig. 2.
Evidence in relation to the model is presented in
Table 1.
HIV Core Beliefs/HIV Stigma and Conditional
Assumptions
We suggest that internalised HIV stigma [34] (endorsing
negative beliefs and feelings about HIV about oneself as an
HIV-positive person) is a key distal determinant of HIV
disclosure anxiety. Indeed, a relationship between HIV
stigma and HIV disclosure concerns has been shown
[21, 22], and there is evidence of an association between
HIV stigma and reduced levels of HIV disclosure [8, 12].
Feelings of shame, perhaps based on actual experiences of
discrimination after previous disclosure [12] (enacted
stigma [34]) or difficulties in adjusting to an HIV-positive
diagnosis, are argued to predispose individuals to HIV
disclosure anxiety. Indeed, feelings of shame have been
reported to inhibit HIV disclosure [35], and conversely
self-compassion has been associated with HIV disclosure
[36]. Negative beliefs about HIV (e.g., ‘‘People who are
HIV-positive will have a short life expectancy’’) are likely
to contribute to internalised stigma. Illness beliefs are
included as important determinants of health behaviour in
many theoretical models [13] and have shown to be related
to depression in HIV-positive individuals [37]. There may
be broader core beliefs about illness (e.g., ‘‘people who are
ill are to blame’’) and the self (e.g., ‘‘I am not a strong
person’’) that impact upon HIV core beliefs.
Our model states that several contextual aspects are
likely to influence the extent to which internalised HIV
stigma is experienced and negative HIV core beliefs are
endorsed. We use distinctions offered by Skovdal et al.
[38]. Aspects of the symbolic context (e.g., community
values, community HIV stigma, gender and sexuality rep-
resentations) may impact upon internalised HIV stigma and
HIV disclosure anxiety. Indeed, greater HIV disclosure
concerns been reported in women [23], and heterosexual
participants [23–25]. The material context may be relevant,
consistent with evidence that greater disclosure fear is
AIDS Behav (2017) 21:1–11 5
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reported in those with no income [39]. Finally, the rela-
tional context is likely to influence internalised HIV stigma
and HIV disclosure anxiety. For example, the HIV status of
one’s partner and family members, their beliefs about HIV
and HIV disclosure, and the quality of these relationships
(e.g., the level of perceived trust), may influence inter-
nalised HIV stigma and HIV disclosure anxiety.
Cognitive models of depression [40] suggest that core
beliefs produce conditional assumptions or rules that pro-
tect against distress and are activated in specific situations.
For example, a belief that HIV is shameful may lead the
individual to believe that they must hide their status from
others to avoid being devastated by rejection (e.g., ‘‘If I
hide my status, then I will be safe’’). Such rules for living
can, however, be unhelpful if they form a barrier to per-
sonally important goals (e.g., accessing support). Our
model, therefore, includes the construct of conditional
disclosure assumptions, arising from internalised HIV
stigma.
Trigger Event
We argue that HIV disclosure anxiety is heightened by
specific events or situations which are interpreted in the
light of negative core HIV beliefs and conditional
assumptions about HIV disclosure. Indeed, our review
suggested that HIV disclosure anxiety is present in par-
ticular contexts (e.g., taking ART medication in social
situations, attending clinic, sexual situations) where HIV
disclosure is thought to be required or wanted (direct
disclosure), or where there might be a concern that one’s
status will be revealed involuntarily or guessed (indirect or
guessed disclosure). For example with the latter situation,
individuals may be concerned that their antiretroviral use
or their visits to clinic will be observed by others and that
their status will, therefore, be inferred. An HIV diagnosis is
likely to be an initial trigger to HIV disclosure anxiety but
subsequently episodes of disclosure anxiety may be
prompted by different determinants.
Within sexual relationships, a sense of responsibility to
one’s partner and/or a concern about onward HIV trans-
mission may trigger anxiety about disclosing, with a nor-
mative belief that one should share one’s status. This may
occur in new relationships or when there is increasing
depth within relationships. Within friendships, a desire for
closeness may trigger a perceived need to disclosure. Such
situations may trigger disclosure approach goals (e.g.,
sharing one’s status to enhance relationship quality) or
disclosure avoidance goals (e.g., hiding one’s status to
avoid rejection and reduce potential relationship conflict)
[41].
Threat Interpretation and HIV Disclosure Anxiety
A sense of threat (usually interpersonal in nature) is central
to HIV disclosure anxiety. Our model uses a quasi-math-
ematical equation taken from a cognitive-behavioural
model of health anxiety [33] to describe this threat inter-
pretation: the probability of a negative outcome multiplied
Table 1 Evidence for model components
Model component Sub-component Evidence
HIV core beliefs/
HIV stigma
Higher levels of HIV stigma associated with higher levels of HIV disclosure concerns [21, 22] and




Context Greater disclosure concerns in women [23] and heterosexual samples [23–25]. More disclosure fear
in those with no income [39]. Different patterns of disclosure in males and females, and in marital
and non-marital relationships [39]. More partner disclosure associated with better relationship
quality [42]
Trigger event Various studies report anxiety about HIV disclosure in relation to ART initiation (e.g., [47]), ART
adherence (e.g., [48]), engagement in care (e.g., [49]), and safer sex [50]
Threat
interpretation
Many examples of perceived threat associated with HIV disclosure. No evidence of hypothesized
components of threat interpretation
Maintaining factors Behavioural Hiding of bottle feeding [45], only disclosing to other HIV? people [12], using condoms instead of
disclosing [44], avoiding sexual relationships [44], missing ART doses (e.g., [51]), not initiating




HIV disclosure concerns associated with anxiety [20, 21]
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by the awfulness of the outcome, divided by coping plus
rescue factors.
Greater anxiety will occur if the probability of negative
outcomes (e.g., rejection from others) is predicted to be
high. The greater the extent to which these outcomes are
judged as awful, the more that anxiety is a likely outcome.
Although these two synergistic components of perceived
threat have not been separated in the HIV disclosure lit-
erature, it is likely that fears about discrimination/stigma,
rejection, the effect on others and violence from studies
included in the systematic review, are heightened by both
perceptions of the likelihood and awfulness of the antici-
pated outcome. These perceptions may be experienced in
the form of negative automatic thoughts or anxiety-laden
images. Coping factors refer to the confidence in being able
and prepared to face the anxiety of both sharing one’s HIV
status and the outcome of HIV disclosure (and to cope with
this anxiety). This may or may not be related to one’s
actual ability to manage anxiety in the feared situation or
to disclose effectively. Perceived coping ability (related to
the concept of self-efficacy) is likely to predict the extent to
which an individual is motivated to face and persist in
challenging situations related to status sharing. Rescue
refers to the perceived ability of others to minimise the
individual’s anxiety about disclosing and to provide helpful
support.
Previous disclosure experiences (and how these are
appraised) are likely to influence all of the elements of the
threat equation. Some theorists have, indeed, specified a
role for previous disclosure experiences in making subse-
quent disclosure decisions [41] and there is evidence that
negative disclosure experiences inhibit future HIV disclo-
sure [12]. One of the consequences of not sharing one’s
HIV status is that there is no opportunity for the person
living with HIV to learn that others’ responses to HIV
disclosure may be benign or supportive (or that they
themselves can tolerate negative responses). As a result
there may be an ongoing fear about disclosing, with less
social support available if the individual chooses to share
their status in the future [12].
Contextual factors will influence the extent to which the
situation is perceived as threatening. Relational factors are
argued to be particularly important. There is evidence that
women living with HIV often disclose their status to family
members first and then to partners, whereas men are more
likely to disclose to partners first [39]. There is also evi-
dence that married individuals are more likely to disclose
to partners, whereas non-married individuals tend to share
their status with their family [39]. Finally, the quality of
intimate relationships is associated with partner disclosure
occurrence [42]. These patterns of disclosure may signal
differing levels of anxiety by characteristics of the dis-
closer and their assessment of interpersonal threat
associated with the disclosure recipient. Given the per-
ceived threat associated with HIV disclosure, it is unsur-
prising that ambivalence about whether/when to disclose is
experienced. Indeed, one study reports the fear of aban-
donment weighing against the need for support and the
desire to raise risk awareness in HIV disclosure decisions
[43].
Maintaining Factors
Central to our model is the role of maintaining processes. It
is these thoughts, feelings and behaviours that potentially
maximise the negative impact of HIV disclosure anxiety
and turn normative anxiety into something more prob-
lematic for the individual.
Behavioural Factors
The most powerful anxiety maintenance process is avoid-
ance of situations that provoke anxiety (situations where
one’s status may be shared or inferred). The individual
may, for example, avoid telling others about being HIV-
positive and as a result may use condoms in sexual rela-
tionships rather than disclosing, only take medication when
alone, and avoid sexual relationships completely to avoid
sharing one’s status [44]. It is important to note that
avoidance is a self-protective strategy that is helpful in the
short term (as it reduces anxiety). Avoidance, however,
reinforces threat interpretations as the individual fails to
disconfirm anxious predictions and they remain alert to
future threats [33]. We include avoidance in our model to
signal situations where widespread avoidance of disclosure
anxiety-provoking situations is part of a maintaining cycle
that has a negative impact on individual functioning (given
the effects of, for example, ongoing anxiety and reduced
social support).
Closely associated with avoidance is the use of safety
seeking behaviours [32]. These are behaviours intended to
prevent or minimise feared negative outcomes that may
involve entering the feared situation but using subtle
avoidance. Evidence from the systematic review includes
reports of the hiding of bottle feeding and making excuses
for bottle feeding [45]. Other examples of safety seeking
behaviours might include only disclosing to other known
HIV-positive people, attempting to assess the potential
recipient’s HIV attitudes before deciding whether to dis-
close, or presenting a plausible alternative account for
medication use [12]. Again, these strategies are not inher-
ently unhelpful but they can become so if they play a part
in a cycle that maintains perceived threat and this has a
significant impact on functioning.
AIDS Behav (2017) 21:1–11 7
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Cognitive Factors
Cognitive factors maintaining disclosure anxiety may
include preoccupation with thoughts about disclosing or
others finding out about one’s HIV status, negative rumi-
nation and self-focused attention in social situations where
one’s HIV status is not known. There may be attentional
biases, with a focus on attending to negative talk about
people with HIV, as well as scanning for information about
HIV and other people’s views about the condition. We
suggest these factors based on the clinical anxiety literature
[32, 33]. They have not been investigated, to our knowl-
edge, in HIV-positive populations.
Affective and Physiological Factors
There is evidence that HIV disclosure concerns are posi-
tively associated with general levels of anxiety [20, 21].
High levels of general anxiety are likely to maintain beliefs
about interpersonal threat relating to specific disclosure
situations. We also propose that HIV disclosure anxiety is
characterised by increased arousal (e.g., sweating, feeling
hot) in situations where disclosure of one’s status is pos-
sible or required. This aversive nature of these symptoms
and the desire to use avoidance to manage them serves to
maintain anxiety, similar to processes occurring in social
anxiety [32].
Summary and Conclusions
We present a novel cognitive model of HIV disclosure
anxiety that attempts to both explain the nature of high
level of anxiety about sharing one’s HIV-positive status
and to suggest avenues for therapeutic intervention. Our
model is the first HIV disclosure model that we are aware
of to focus on the role of anxiety and factors that maintain
HIV disclosure threat responses. The model is based on
HIV CORE BELIEFS/HIV STIGMA
(e.g., being HIV-positive is shameful)
CONDITIONAL ASSUMPTIONS
(e.g., “Hiding being HIV-positive 
avoids rejection”)
CONTEXT TRIGGER EVENT
(e.g., gender, relational) (e.g., new partner, starting 
ART, HIV-positive diagnosis)
THREAT INTERPRETATION





(e.g., anxiety, low mood)
PHYSIOLOGICAL COGNITIVE
(e.g., arousal, physical reactions) (e.g., rumination, 
preoccupation)
BEHAVIOURAL 
(e.g., avoidance, safety seeking behaviours, scanning, seeking reassurance)
Fig. 2 A model of HIV disclosure anxiety
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robust clinical models of anxiety disorders, adapted for the
specific context of HIV disclosure. Our model differs from
health anxiety models [33] in having the interpretation of
future interpersonal situations at its core versus the inter-
pretation of one’s own symptoms. It also highlights a
specific role for (a) deeper level cognitions about the self in
relation to the condition (e.g., internalised HIV stigma
beliefs) (b) context, compared with health anxiety models.
Our model differs from social anxiety models [32] as it
does not have self-focussed attention at its core, and
instead highlights both a specific role for context, and
provides more detail on the threat interpretation/feared
prediction.
There is evidence for some aspects of the model (e.g.,
the relationship between HIV stigma and HIV disclosure
anxiety, and catastrophic beliefs concerning HIV disclo-
sure outcome). Many components of the model, however,
remain to be investigated (and there is an absence of
standardised measures of HIV disclosure anxiety or its
determinants that will facilitate model testing). For exam-
ple, there have not been any attempts to separate out the
different elements of threat interpretation to investigate
whether the model accurately describes and predicts dis-
closure anxiety. Although there are not current measures of
these beliefs, they could be operationalised and measured
reliably and validly in the future. Another limitation is that
the model does not attempt to explain post-disclosure
outcomes. Future research should attempt to operationalise
key elements of the model (e.g., HIV disclosure anxiety,
disclosure conditional assumptions, threat interpretations,
and disclosure avoidance) so that relationships suggested
by the model can be tested. In addition, the model would
benefit from studies examining the prevalence of disclosure
anxiety-related impact on quality of life and functioning in
different HIV-positive populations.
Our model has clear clinical implications. In particular,
we suggest that the existence of HIV disclosure anxiety
should be normalised and the maintenance components of
the model should be focused on in interventions where
individuals are most affected by HIV disclosure anxiety
and are motivated to consider sharing their status (threat
interpretations, avoidance, safety-seeking behaviours,
rumination, and attentional focus). Many of the cognitive-
behavioural strategies used in treating health anxiety and
social anxiety could be relevant for working with individ-
uals who are most anxious about sharing their status. Such
techniques could involve developing ways to challenge
anxiogenic cognitions (e.g., cognitive restructuring and
behavioural experiments), graded exposure to feared situ-
ations with the withdrawal of safety-seeking behaviours,
teaching disclosure communication skills to enhance per-
ceptions of coping, exploring different explanations for
disclosure anxiety (Theory A versus Theory B), and
accessing HIV disclosure support. In addition, motivational
interviewing could be used to address disclosure ambiva-
lence. The goals of such an intervention might be to help
the individual to understand what maintains their high
levels of anxiety, and to enable them to manage anxiety
such that they can make a considered decision about how to
respond to threat interpretations. This may help to break
the HIV disclosure anxiety maintaining cycle, reducing
both the preoccupation with HIV disclosure and disabling
levels of anxiety. This may enable the sharing of one’s
status in situations where the individual wants to disclose,
or the management of anxiety in situations where one’s
status is not known and there is no motivation to disclose.
We argue that developing a new theory-based inter-
vention to minimise significant levels of HIV disclosure
anxiety, is warranted, given the limited evidence of exist-
ing effective interventions to reduce anxiety about HIV
disclosure from the systematic review [17–19]. It is inter-
esting to note that the most promising of the interventions
included in the review [17] used some of the components
that we suggest might be beneficial.
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